Skip to Content

Notice

Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Products

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on requirements for reporting and recordkeeping, general and specific requirements, and the availability of sample electronic products for manufacturers and distributors of electronic products.

DATES:

Submit either electronic or written comments on the collection of information by January 9, 2017.

ADDRESSES:

You may submit comments as follows:

Electronic Submissions

Submit electronic comments in the following way:

  • Federal eRulemaking Portal: http://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to http://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on http://www.regulations.gov.
  • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see “Written/Paper Submissions” and “Instructions”).

Written/Paper Submissions

Submit written/paper submissions as follows:

  • Mail/Hand delivery/Courier (for written/paper submissions): Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
  • For written/paper comments submitted to the Division of Dockets Management, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in “Instructions.”

Instructions: All submissions received must include the Docket No. FDA-2013-N-0618 for “Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Products.” Received comments will be placed in the docket and, except for those submitted as “Confidential Submissions,” publicly viewable at http://www.regulations.gov or at the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.

  • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states “THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.” The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on http://www.regulations.gov. Submit both copies to the Division of Dockets Management. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as “confidential.” Any information marked as “confidential” will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: http://www.fda.gov/​regulatoryinformation/​dockets/​default.htm.

Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the “Search” box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 10A63, 11601 Landsdown St., North Bethesda, MD 20852, PRAStaff@fda.hhs.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Under the PRA (44 U.S.C. 3501-3520), Federal Agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. “Collection of information” is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document.

With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, Start Printed Page 79031when appropriate, and other forms of information technology.

Electronic Products—21 CFR parts 1002 Through 1010 (OMB Control Number 0910-0025)—Extension

Under sections 532 through 542 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360ii through 360ss), FDA has the responsibility to protect the public from unnecessary exposure of radiation from electronic products. The regulations issued under these authorities are listed in Title 21 of the Code of Federal Regulations, chapter I, subchapter J, parts 1000 through 1050 (21 CFR parts 1000 through 1050).

Section 532 of the FD&C Act directs the Secretary of the Department of Health and Human Services (the Secretary), to establish and carry out an electronic product radiation control program, including the development, issuance, and administration of performance standards to control the emission of electronic product radiation from electronic products. The program is designed to protect the public health and safety from electronic radiation, and the FD&C Act authorizes the Secretary to procure (by negotiation or otherwise) electronic products for research and testing purposes and to sell or otherwise dispose of such products. Section 534(g) of the FD&C Act directs the Secretary to review and evaluate industry testing programs on a continuing basis; and section 535(e) and (f) of the FD&C Act directs the Secretary to immediately notify manufacturers of, and ensure correction of, radiation defects or noncompliance with performance standards. Section 537(b) of the FD&C Act contains the authority to require manufacturers of electronic products to establish and maintain records (including testing records), make reports, and provide information to determine whether the manufacturer has acted in compliance.

The regulations under parts 1002 through 1010 specify reports to be provided by manufacturers and distributors to FDA and records to be maintained in the event of an investigation of a safety concern or a product recall. FDA conducts laboratory compliance testing of products covered by regulations for product standards in parts 1020, 1030, 1040, and 1050.

FDA details product-specific performance standards that specify information to be supplied with the product or require specific reports. The information collections are either specifically called for in the FD&C Act or were developed to aid the Agency in performing its obligations under the FD&C Act. The data reported to FDA and the records maintained are used by FDA and the industry to make decisions and take actions that protect the public from radiation hazards presented by electronic products. This information refers to the identification of, location of, operational characteristics of, quality assurance programs for, and problem identification and correction of electronic products. The data provided to users and others are intended to encourage actions to reduce or eliminate radiation exposures.

FDA uses the following forms to aid respondents in the submission of information for this information collection:

Form FDA 2579 “Report of Assembly of a Diagnostic X-Ray System”

Form FDA 2767 “Notice of Availability of Sample Electronic Product”

Form FDA 2877 “Declaration for Imported Electronic Products Subject to Radiation Control Standards”

Form FDA 3649 “Accidental Radiation Occurrence (ARO)”

Form FDA 3626 “A Guide for the Submission of Initial Reports on Diagnostic X-Ray Systems and Their Major Components”

Form FDA 3627 “Diagnostic X-Ray CT Products Radiation Safety Report”

Form FDA 3628 “General Annual Report (Includes Medical, Analytical, and Industrial X-Ray Products Annual Report)”

Form FDA 3629 “Abbreviated Report”

Form FDA 3630 “Guide for Preparing Product Reports on Sunlamps and Sunlamp Products”

Form FDA 3631 “Guide for Preparing Annual Reports on Radiation Safety Testing of Sunlamp Products”

Form FDA 3632 “Guide for Preparing Product Reports on Lasers and Products Containing Lasers”

Form FDA 3633 “General Variance Request”

Form FDA 3634 “Television Products Annual Report”

Form FDA 3635 “Laser Light Show Notification”

Form FDA 3636 “Guide for Preparing Annual Reports on Radiation Safety Testing of Laser and Laser Light Show Products”

Form FDA 3637 “Laser Original Equipment Manufacturer (OEM) Report”

Form FDA 3638 “Guide for Filing Annual Reports for X-Ray Components and Systems”

Form FDA 3639 “Guidance for the Submission of Cabinet X-Ray System Reports Pursuant to 21 CFR 1020.40

Form FDA 3640 “Reporting Guide for Laser Light Shows and Displays”

Form FDA 3147 “Application for a Variance From 21 CFR 1040.11(c) for a Laser Light Show, Display, or Device”

Form FDA 3641 “Cabinet X-Ray Annual Report”

Form FDA 3642 “General Correspondence”

Form FDA 3643 “Microwave Oven Products Annual Report”

Form FDA 3644 “Guide for Preparing Product Reports for Ultrasonic Therapy Products”

Form FDA 3645 “Guide for Preparing Annual Reports for Ultrasonic Therapy Products”

Form FDA 3646 “Mercury Vapor Lamp Products Radiation Safety Report”

Form FDA 3647 “Guide for Preparing Annual Reports on Radiation Safety Testing of Mercury Vapor Lamps”

Form FDA 3659 “Reporting and Compliance Guide for Television Products”

Form FDA 3660 “Guidance for Preparing Reports on Radiation Safety of Microwave Ovens”

Form FDA 3661 “A Guide for the Submission of an Abbreviated Report on X-Ray Tables, Cradles, Film Changers or Cassette Holders Intended for Diagnostic Use”

Form FDA 3662 “A Guide for the Submission of an Abbreviated Radiation Safety Report on Cephalometric Devices Intended for Diagnostic Use”

Form FDA 3663 “Abbreviated Reports on Radiation Safety for Microwave Products (Other than Microwave Ovens)”

Form FDA 3801 “Guide for Preparing Initial Reports and Model Change Reports on Medical Ultraviolet Lamps and Products Containing Such Lamps”

The respondents to this information collection are electronic product and x-ray manufacturers, importers, and assemblers. The burden estimates were derived by consultation with FDA and industry personnel, and are based on data collected from industry, including recent product report submissions. An evaluation of the type and scope of information requested was also used to derive some time estimates.

FDA estimates the burden of this collection of information as follows:Start Printed Page 79032

Table 1—Estimated Annual Reporting Burden 12

Activity/21 CFR sectionFDA formNumber of respondentsNumber of responses per respondentTotal annual responsesAverage burden per responseTotal hours
Product reports—1002.10(a) through (k)3626—Diagnostic x-ray1,4002.23,0802473,920
3627—CT x-ray 3639—Cabinet x-ray 3632—Laser 3640—Laser light show 3630—Sunlamp 3646—Mercury vapor lamp 3644—Ultrasonic therapy
3659—TV
3660—Microwave oven
3801—UV lamps
Product safety or testing changes—1002.11(a) and (b)4802.51,2000.5 (30 minutes)600
Abbreviated reports—1002.123629—General abbreviated report601.81085540
3661—X-ray tables, etc. 3662—Cephalometric device 3663—Microwave products (non-oven)
Annual reports—1002.13(a) and (b)3628—General1,6601.32,1581838,844
3634—TV
3638—Diagnostic x-ray 3641—Cabinet x-ray 3643—Microwave oven 3636—Laser 3631—Sunlamp 3647—Mercury vapor lamp 3645—Ultrasonic therapy
Quarterly updates for new models—1002.13(c)1201.41680.5 (30 minutes)84
Accidental radiation occurrence reports—1002.203649—ARO306.72012402
Exemption requests—1002.50(a) and 1002.513642—General correspondence41.3515
Product and sample information—1005.102767—Sample product5150.1 (6 minutes)1
Identification information and compliance status—1005.252877—Imports declaration12,6202.531,5500.2 (12 minutes)6,310
Alternate means of certification—1010.2(d)122510
Variance—1010.4(b)3633—General variance request 3147—Laser show variance request 3635—Laser show notification3501.13851.2 (1 hour and 12 minutes)462
Exemption from performance standards—1010.5(c) and (d)1112222
Alternate test procedures—1010.131111010
Report of assembly of diagnostic x-ray components—1020.30(d), (d)(1), and (2)2579—Assembler report1,2303441,8200.30 (18 minutes)12,546
Microwave oven exemption from warning labels—1030.10(c)(6)(iv)11111
Laser products registration—1040.10(a)(3)(i)3637—Original equipment manufacturer (OEM) report702.92033609
Total134,366
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
2 Numbers have been rounded.
Start Printed Page 79033

Table 2—Estimated Annual Recordkeeping Burden 1 2

Activity/21 CFR sectionNumber of recordkeepersNumber of records per recordkeeperTotal annual recordsAverage burden per recordkeepingTotal hours
Manufacturers records—1002.30 and 1002.31(a)1,6501,6502,722,5000.12 (7 minutes)326,700
Dealer/distributor records—1002.40 and 1002.413,11050155,5000.05 (30 minutes)7,775
Information on diagnostic x-ray systems—1020.30(g)501500.5 (30 minutes)25
Laser products distribution records—1040.10(a)(3)(ii)70170170
Total334,570
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
2 Numbers have been rounded.

Table 3—Estimated Annual Third-Party Disclosure Burden 1 2

Activity/21 CFR sectionNumber of respondentsNumber of disclosures per respondentTotal annual disclosuresAverage burden per disclosureTotal hours
Technical and safety information for users—1002.31111212
Dealer/distributor records—1002.40 and 1002.4130390190
Television receiver critical component warning—1020.10(c)(4)11111
Cold cathode tubes—1020.20(c)(4)11111
Information on diagnostic x-ray systems—1020.30(g)61655330
Statement of maximum line current of x-ray systems—1020.30(g)(2)6161060
Diagnostic x-ray system safety and technical information—1020.30(h)(1) through (4)6162001,200
Fluoroscopic x-ray system safety and technical information—1020.30(h)(5) and (6) and 1020.32(a)(1), (g), and (j)(4)51525125
CT equipment—1020.33(c), (d), (g)(4), and (j)515150750
Cabinet x-ray systems information—1020.40(c)(9)(i) and (ii)61640240
Microwave oven radiation safety instructions—1030.10(c)(4)1112020
Microwave oven safety information and instructions—1030.10(c)(5)(i) through (iv)1112020
Microwave oven warning labels—1030.10(c)(6)(iii)11111
Laser products information—1040.10(h)(1)(i) through (vi)3132060
Laser product service information—1040.10(h)(2)(i) and (ii)3132060
Medical laser product instructions—1040.11(a)(2)2121020
Sunlamp products instructions—1040.201111010
Mercury vapor lamp labeling—1040.30(c)(1)(ii)11111
Mercury vapor lamp permanently affixed labels—1040.30(c)(2)11111
Ultrasonic therapy products—1050.10(d)(1) through (4), (f)(1), and (f)(2)(iii)1115656
Total3,058
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
2 Numbers have been rounded.
Start Signature

Dated: November 4, 2016.

Leslie Kux,

Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2016-27199 Filed 11-9-16; 8:45 am]

BILLING CODE 4164-01-P